Leaflet NALTREXONA AMOMED 50mg film-coated tablets


Indicated for: opioid dependence; alcohol dependence

Route of administration: oral

Substance: naltrexone (opioid antagonist)

ATC: N07BB04 (Nervous system | Drugs used in addictive disorders | Drugs used in alcohol dependence)

Naltrexone is an opioid receptor antagonist used for the treatment of opioid and alcohol dependence. It works by blocking the effects of opioids and reducing cravings, helping patients maintain abstinence.

The medication is taken orally, usually once daily, with the dose adjusted based on the patient's needs. Common side effects include nausea, headaches, insomnia, and irritability.

Naltrexone is contraindicated in patients actively using opioids or with severe hepatic impairment. Its use also requires careful monitoring to prevent severe adverse reactions.

This medication is an important option for patients seeking to quit opioids or alcohol, helping to reduce relapses and improve quality of life.

General data about NALTREXONA AMOMED 50mg

  • Substance: naltrexone
  • Date of last drug list: 01-06-2026
  • Commercial code: W66185003
  • Concentration: 50mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 28
  • Product type: generic
  • Price: 247.31 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: HAUPT PHARMA WOLFRATSHAUSEN GMBH - GERMANIA
  • Holder: AMOMED PHARMA GMBH - AUSTRIA
  • Number: 11940/2019/03
  • Shelf life: 3 years

Combinations with other substances

Compensation lists for NALTREXONA AMOMED 50mg Amomed

NHP 11.1 (C2) - Treatment of drug addiction

Price

Copayment

Patient

247.31 RON

247.31 RON

0.00 RON